← Eichor
Study identifier: NCT07410000 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty

Condition: Pain Management · Total Hip Arthroplasty  ·  Sponsor: Bursa City Hospital

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This prospective, randomized, double-blind study evaluates the analgesic effectiveness of the ultrasound-guided Quadro-Iliac Plane (QIP) block in patients undergoing primary total hip arthroplasty. The QIP block is a recently described fascial plane block. Patients will be randomized to receive either a QIP block with local anesthetic or a sham block with saline. The primary outcome is 24-hour opioid consumption. Secondary outcomes include motor block, dermatomal sensory assessment, pain scores, rescue analgesic requirement, quality of recovery (QoR-15), and opioid-related side effects.

This description comes directly from the study's public registry record.

Talk to the study team

Mursel Ekinci, Assoc prof,MD  ·  +905067137596  ·  drmurselekinci@gmail.com

Mustafa Dikici, MD  ·  +905055346540  ·  mus.dikici88@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Bursa City HospitalBursa, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07410000